Stratec SE

XTRA:SBS Voorraadrapport

Marktkapitalisatie: €321.5m

Stratec Inkomsten in het verleden

Verleden criteriumcontroles 1/6

De winst van Stratec is gedaald met een gemiddeld jaarlijks percentage van -8.6%, terwijl de winst van de Medical Equipment -industrie jaarlijks daalde met 1.1%. De inkomsten zijn groeide met een gemiddeld percentage van 2.6% per jaar. Het rendement op het eigen vermogen Stratec bedraagt 4.4% en de nettomarge bedraagt 4%.

Belangrijke informatie

-8.6%

Groei van de winst

-8.8%

Groei van de winst per aandeel

Medical Equipment Groei van de industrie4.3%
Inkomstengroei2.6%
Rendement op eigen vermogen4.4%
Nettomarge4.0%
Laatste winstupdate30 Sep 2024

Recente prestatie-updates uit het verleden

Recent updates

With A 25% Price Drop For Stratec SE (ETR:SBS) You'll Still Get What You Pay For

Nov 09
With A 25% Price Drop For Stratec SE (ETR:SBS) You'll Still Get What You Pay For

Returns At Stratec (ETR:SBS) Appear To Be Weighed Down

Oct 26
Returns At Stratec (ETR:SBS) Appear To Be Weighed Down

Here's Why It's Unlikely That Stratec SE's (ETR:SBS) CEO Will See A Pay Rise This Year

May 11
Here's Why It's Unlikely That Stratec SE's (ETR:SBS) CEO Will See A Pay Rise This Year

Stratec's (ETR:SBS) Dividend Will Be Reduced To €0.55

Apr 11
Stratec's (ETR:SBS) Dividend Will Be Reduced To €0.55

Stratec SE Just Missed EPS By 24%: Here's What Analysts Think Will Happen Next

Apr 01
Stratec SE Just Missed EPS By 24%: Here's What Analysts Think Will Happen Next

Stratec (ETR:SBS) Has Announced That Its Dividend Will Be Reduced To €0.55

Mar 28
Stratec (ETR:SBS) Has Announced That Its Dividend Will Be Reduced To €0.55

Is There An Opportunity With Stratec SE's (ETR:SBS) 36% Undervaluation?

Dec 21
Is There An Opportunity With Stratec SE's (ETR:SBS) 36% Undervaluation?

Slowing Rates Of Return At Stratec (ETR:SBS) Leave Little Room For Excitement

Nov 03
Slowing Rates Of Return At Stratec (ETR:SBS) Leave Little Room For Excitement

We Think Stratec (ETR:SBS) Is Taking Some Risk With Its Debt

Oct 19
We Think Stratec (ETR:SBS) Is Taking Some Risk With Its Debt

Return Trends At Stratec (ETR:SBS) Aren't Appealing

Jul 12
Return Trends At Stratec (ETR:SBS) Aren't Appealing

Stratec SE (ETR:SBS) Shares Could Be 43% Below Their Intrinsic Value Estimate

Jun 27
Stratec SE (ETR:SBS) Shares Could Be 43% Below Their Intrinsic Value Estimate

Is Stratec (ETR:SBS) Using Too Much Debt?

May 25
Is Stratec (ETR:SBS) Using Too Much Debt?

Stratec's (ETR:SBS) Upcoming Dividend Will Be Larger Than Last Year's

Apr 02
Stratec's (ETR:SBS) Upcoming Dividend Will Be Larger Than Last Year's

The Returns At Stratec (ETR:SBS) Aren't Growing

Jan 28
The Returns At Stratec (ETR:SBS) Aren't Growing

Calculating The Fair Value Of Stratec SE (ETR:SBS)

Jan 12
Calculating The Fair Value Of Stratec SE (ETR:SBS)

Is Stratec (ETR:SBS) A Risky Investment?

Oct 26
Is Stratec (ETR:SBS) A Risky Investment?

Returns On Capital At Stratec (ETR:SBS) Have Stalled

Oct 11
Returns On Capital At Stratec (ETR:SBS) Have Stalled

Stratec (ETR:SBS) Has A Pretty Healthy Balance Sheet

Jul 23
Stratec (ETR:SBS) Has A Pretty Healthy Balance Sheet

Should You Be Adding Stratec (ETR:SBS) To Your Watchlist Today?

Jul 07
Should You Be Adding Stratec (ETR:SBS) To Your Watchlist Today?

Stratec's (ETR:SBS) Shareholders Will Receive A Bigger Dividend Than Last Year

May 12
Stratec's (ETR:SBS) Shareholders Will Receive A Bigger Dividend Than Last Year

Stratec (ETR:SBS) Has Announced That It Will Be Increasing Its Dividend To €0.95

Apr 28
Stratec (ETR:SBS) Has Announced That It Will Be Increasing Its Dividend To €0.95

Analysts Are Updating Their Stratec SE (ETR:SBS) Estimates After Its Annual Results

Apr 03
Analysts Are Updating Their Stratec SE (ETR:SBS) Estimates After Its Annual Results

Stratec's (ETR:SBS) Dividend Will Be Increased To €0.95

Apr 02
Stratec's (ETR:SBS) Dividend Will Be Increased To €0.95

These 4 Measures Indicate That Stratec (ETR:SBS) Is Using Debt Reasonably Well

Mar 13
These 4 Measures Indicate That Stratec (ETR:SBS) Is Using Debt Reasonably Well

Stratec (ETR:SBS) Is Doing The Right Things To Multiply Its Share Price

Feb 12
Stratec (ETR:SBS) Is Doing The Right Things To Multiply Its Share Price

Do Stratec's (ETR:SBS) Earnings Warrant Your Attention?

Jan 27
Do Stratec's (ETR:SBS) Earnings Warrant Your Attention?

We Think Stratec (ETR:SBS) Can Stay On Top Of Its Debt

Dec 05
We Think Stratec (ETR:SBS) Can Stay On Top Of Its Debt

Slowing Rates Of Return At Stratec (ETR:SBS) Leave Little Room For Excitement

Nov 02
Slowing Rates Of Return At Stratec (ETR:SBS) Leave Little Room For Excitement

Do Stratec's (ETR:SBS) Earnings Warrant Your Attention?

Oct 18
Do Stratec's (ETR:SBS) Earnings Warrant Your Attention?

Is Stratec (ETR:SBS) Using Too Much Debt?

Sep 03
Is Stratec (ETR:SBS) Using Too Much Debt?

Stratec (ETR:SBS) Will Want To Turn Around Its Return Trends

Aug 03
Stratec (ETR:SBS) Will Want To Turn Around Its Return Trends

Should You Be Adding Stratec (ETR:SBS) To Your Watchlist Today?

Jul 20
Should You Be Adding Stratec (ETR:SBS) To Your Watchlist Today?

Calculating The Intrinsic Value Of Stratec SE (ETR:SBS)

Jun 14
Calculating The Intrinsic Value Of Stratec SE (ETR:SBS)

Here's Why Stratec (ETR:SBS) Can Manage Its Debt Responsibly

May 31
Here's Why Stratec (ETR:SBS) Can Manage Its Debt Responsibly

Opbrengsten en kosten

Hoe Stratec geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

XTRA:SBS Opbrengsten, kosten en inkomsten (EUR Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Sep 24251103710
30 Jun 24256153410
31 Mar 2425212339
31 Dec 2326213329
30 Sep 2325512319
30 Jun 2326219327
31 Mar 2326019327
31 Dec 2227529307
30 Sep 2227028308
30 Jun 2226927299
31 Mar 2229140289
31 Dec 2128740289
30 Sep 2129646256
30 Jun 2128641266
31 Mar 2126635277
31 Dec 2025028288
30 Sep 20235242810
30 Jun 20225212810
31 Mar 2022417278
31 Dec 1921414268
30 Sep 19212142510
30 Jun 1920714259
31 Mar 19195112510
31 Dec 18188112410
30 Sep 1819316269
30 Jun 18197232610
31 Mar 18198242710
31 Dec 17207273110
30 Sep 1720828328
30 Jun 1720620338
31 Mar 1720319348
31 Dec 1618519298
30 Sep 16166142610
30 Jun 16155192210
31 Mar 1614421189
31 Dec 1514722188
30 Sep 1514722185
30 Jun 1514621175
31 Mar 1514521165
31 Dec 1414520175
30 Sep 1414219167
30 Jun 1413718166
31 Mar 1413216175
31 Dec 1312815165

Kwaliteitswinsten: SBS heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (4%) SBS } zijn lager dan vorig jaar (4.7%).

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: De winst van SBS is de afgelopen 5 jaar met 8.6% per jaar gedaald.

Versnelling van de groei: De winstgroei SBS is het afgelopen jaar negatief geweest en kan daarom niet worden vergeleken met het 5-jarig gemiddelde.

Winst versus industrie: SBS had het afgelopen jaar een negatieve winstgroei ( -16.8% ), waardoor het moeilijk is om te vergelijken met het branchegemiddelde Medical Equipment ( 10.1% ).

Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 4.4% ) van SBS wordt als laag beschouwd.

Rendement op activa

Rendement op geïnvesteerd vermogen

Ontdek sterk presterende bedrijven uit het verleden

7D

1Y

7D

1Y

7D

1Y